Pharnext (XPAR:ALPHA) Total Liabilities : €38.12 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharnext Total Liabilities?

Pharnext's Total Liabilities for the quarter that ended in Dec. 2023 was €38.12 Mil.

Pharnext's quarterly Total Liabilities declined from Dec. 2022 (€40.98 Mil) to Jun. 2023 (€35.71 Mil) but then increased from Jun. 2023 (€35.71 Mil) to Dec. 2023 (€38.12 Mil).

Pharnext's annual Total Liabilities increased from Dec. 2021 (€34.31 Mil) to Dec. 2022 (€40.98 Mil) but then declined from Dec. 2022 (€40.98 Mil) to Dec. 2023 (€38.12 Mil).

Pharnext Total Liabilities Historical Data

The historical data trend for Pharnext's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharnext Total Liabilities Chart

Pharnext Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

30.42

33.77

34.31

40.98

38.12

Pharnext Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															34.31	35.50	40.98	35.71	38.12

Pharnext Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pharnext's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.502	+	(26.168	+	2.281
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.172)
	=	38.12

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	4.172	-	-33.951
	=	38.12

Pharnext's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.502	+	(26.168	+	2.281
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.172)
	=	38.12

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	4.172	-	-33.951
	=	38.12

Pharnext Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pharnext's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharnext (XPAR:ALPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

P0X0:Germany

Address

11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130

Website

http://www.pharnext.com

Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Pharnext (XPAR:ALPHA) Headlines

No Headlines